|
Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 10:38AM
|
|
Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
4
|
Resverlogix Corp.
|
Nov 28, 2018 08:59AM
|
|
RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 30, 2020 09:12AM
|
|
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
|
4
|
Resverlogix Corp.
|
Nov 12, 2020 09:46AM
|
|
Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
10
|
Resverlogix Corp.
|
Sep 15, 2020 08:43AM
|
|
Resverlogix Announces Proposed Offering of Units
|
2
|
Resverlogix Corp.
|
May 14, 2019 06:13PM
|
|
Resverlogix Announces Private Placement
|
1
|
Resverlogix Corp.
|
Aug 14, 2020 06:41PM
|
|
Resverlogix Announces Pricing of Unit Offering
|
1
|
Resverlogix Corp.
|
May 15, 2019 08:57AM
|
|
Resverlogix Announces Participation at the Upcoming GCFF Virtual Conference 2020 – Investing in Innovation
|
5
|
Resverlogix Corp.
|
Sep 08, 2020 10:50AM
|
|
Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
8
|
Resverlogix Corp.
|
Mar 31, 2020 08:11AM
|
|
Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 09:10AM
|
|
Resverlogix Announces Participation at Leading, International Scientific Conferences
|
2
|
Resverlogix Corp.
|
Jun 10, 2019 09:36AM
|
|
Resverlogix Announces Overnight Marketed Equity Offering
|
1
|
Resverlogix Corp.
|
Jun 08, 2017 04:18PM
|
|
Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:20PM
|
|
Resverlogix Announces Loan Reduction and Extension
|
1
|
Resverlogix Corp.
|
Aug 02, 2019 12:15PM
|
|
Resverlogix Announces Lifting by TSX of Review
|
5
|
Resverlogix Corp.
|
May 10, 2018 09:15AM
|
|
Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress
|
1
|
Resverlogix Corp.
|
Jun 09, 2020 09:17AM
|
|
Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
1
|
Resverlogix Corp.
|
Aug 28, 2017 08:19AM
|
|
Resverlogix Announces Extension of its Filing Calendar Based on Continuous Disclosure Exemption
|
2
|
Resverlogix Corp.
|
Jul 28, 2020 10:24PM
|
|
Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 08:53AM
|
